M1 Kliniken AG
Research M1 Kliniken AG (M12) on Bullrun: market cap EUR 351.43M, P/E 15.9, dividend yield 6.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerM12
- ExchangeXETRA
- CountryGermany
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyEUR
- Market capEUR 351.43M
- P/E15.9
- Dividend yield6.4%
- Financial periodFY2024
- RevenueEUR 339.18M
- Revenue growth7.2%
- Net incomeEUR 16.02M
- Free cash flowEUR 29.55M
- Gross margin18.8%
Valuation Snapshot
latest market cap is EUR 351.43M; P/E is 15.9; dividend yield is 6.4%.
About M1 Kliniken AG
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin.
Frequently asked questions
What is M1 Kliniken AG's market cap?
M1 Kliniken AG's market capitalization is EUR 351.43M.
What is M1 Kliniken AG's P/E ratio?
M1 Kliniken AG's price-to-earnings (P/E) ratio is 15.9.
Does M1 Kliniken AG pay a dividend?
M1 Kliniken AG has a dividend yield of 6.4%.
What does M1 Kliniken AG do?
M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments.